日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Eubacterium eligens Glycogen synthase (glgA) CSB-YP505622EOW
CSB-EP505622EOW
CSB-BP505622EOW
CSB-MP505622EOW
CSB-EP505622EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Arginine repressor (argR) CSB-YP505623EOW
CSB-EP505623EOW
CSB-BP505623EOW
CSB-MP505623EOW
CSB-EP505623EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP505624EOW
CSB-EP505624EOW
CSB-BP505624EOW
CSB-MP505624EOW
CSB-EP505624EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase (kduI) CSB-YP505625EOW
CSB-EP505625EOW
CSB-BP505625EOW
CSB-MP505625EOW
CSB-EP505625EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Cell division protein SepF (sepF) CSB-YP505626EOW
CSB-EP505626EOW
CSB-BP505626EOW
CSB-MP505626EOW
CSB-EP505626EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Probable tRNA sulfurtransferase (thiI) CSB-YP505627EOW
CSB-EP505627EOW
CSB-BP505627EOW
CSB-MP505627EOW
CSB-EP505627EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Ribosomal protein L11 methyltransferase (prmA) CSB-YP505628EOW
CSB-EP505628EOW
CSB-BP505628EOW
CSB-MP505628EOW
CSB-EP505628EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Phosphoenolpyruvate carboxykinase [ATP] (pckA), partial CSB-YP505629EOW
CSB-EP505629EOW
CSB-BP505629EOW
CSB-MP505629EOW
CSB-EP505629EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Homoserine O-succinyltransferase (metA) CSB-YP505630EOW
CSB-EP505630EOW
CSB-BP505630EOW
CSB-MP505630EOW
CSB-EP505630EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP505631EOW
CSB-EP505631EOW
CSB-BP505631EOW
CSB-MP505631EOW
CSB-EP505631EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Anthranilate phosphoribosyltransferase (trpD) CSB-YP505632EOW
CSB-EP505632EOW
CSB-BP505632EOW
CSB-MP505632EOW
CSB-EP505632EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Glutamate racemase (murI) CSB-YP505633EOW
CSB-EP505633EOW
CSB-BP505633EOW
CSB-MP505633EOW
CSB-EP505633EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Tryptophan synthase alpha chain (trpA) CSB-YP505634EOW
CSB-EP505634EOW
CSB-BP505634EOW
CSB-MP505634EOW
CSB-EP505634EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Indole-3-glycerol phosphate synthase (trpC) CSB-YP505635EOW
CSB-EP505635EOW
CSB-BP505635EOW
CSB-MP505635EOW
CSB-EP505635EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Elongation factor P (efp) CSB-YP505636EOW
CSB-EP505636EOW
CSB-BP505636EOW
CSB-MP505636EOW
CSB-EP505636EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens 3-dehydroquinate dehydratase (aroQ) CSB-YP505637EOW
CSB-EP505637EOW
CSB-BP505637EOW
CSB-MP505637EOW
CSB-EP505637EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens DNA replication and repair protein recF (recF) CSB-YP505638EOW
CSB-EP505638EOW
CSB-BP505638EOW
CSB-MP505638EOW
CSB-EP505638EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase CSB-YP505639EOW
CSB-EP505639EOW
CSB-BP505639EOW
CSB-MP505639EOW
CSB-EP505639EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens D-tyrosyl-tRNA (Tyr) deacylase CSB-YP505640EOW
CSB-EP505640EOW
CSB-BP505640EOW
CSB-MP505640EOW
CSB-EP505640EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eubacterium eligens Proline--tRNA ligase (proS) CSB-YP505641EOW
CSB-EP505641EOW
CSB-BP505641EOW
CSB-MP505641EOW
CSB-EP505641EOW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×